BioCentury
ARTICLE | Finance

Playing CHESS

U.S. obesity play GI Dynamics plans $88.3M Australian IPO

August 8, 2011 7:00 AM UTC

U.S. obesity play GI Dynamics Inc. hopes to gain three years of runway in an Australian IPO to commercialize its EndoBarrier Gastrointestinal Liner to treat obesity and Type II diabetes.

EndoBarrier is intended to mimic the intestinal bypass portion of a surgical gastric bypass procedure without surgery. The liner is placed in the GI tract using endoscopy to create a barrier between food and the wall of the intestine...